Press Release Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald 2 hours ago
Press Release Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates Aug 17